Globus Medical Launches AUTOBAHN® Intramedullary Nailing Platform at 2019 OTA Annual Meeting
Globus Medical, Inc. Class A (GMED)
Last globus medical, inc. class a earnings: 2/20 04:15 pm
Check Earnings Report
US:NYSE Investor Relations:
investors.globusmedical.com
Company Research
Source: GlobeNewswire
AUDUBON, Pa., Sept. 24, 2019 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced the launch of the AUTOBAHN® Nailing System. This comprehensive platform provides advanced clinical solutions for fractures of the tibia and femur. The AUTOBAHN® portfolio includes the Intramedullary Trochanteric Nail, Antegrade/Retrograde Femoral Nail, and Tibial Nail. These new nail offerings are part of Globus Medical’s expansion into the Trauma market over the past 24 months. “Globus’ ability to understand our customers’ needs and to innovate in this space allows us to provide instruments and solutions not previously available to today’s surgeons,” says Barclay Davis, VP of Trauma. The AUTOBAHN® Nailing System complements the available ANTHEM® Plating and ARBOR® External Fixation Systems, and expands the Globus Medical Trauma Portfolio. The AUTOBAHN® Trochanteric Nailing System offers treatment for trochanteric and femoral neck
Show less
Read more
Impact Snapshot
Event Time:
GMED
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GMED alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GMED alerts
High impacting Globus Medical, Inc. Class A news events
Weekly update
A roundup of the hottest topics
GMED
News
- Globus Medical, Inc. (NYSE: GMED) had its price target raised by analysts at Truist Financial Co. from $85.00 to $90.00. They now have a "hold" rating on the stock.MarketBeat
- Confocal Microscope Market is Projected to Reach $1.8 Billion with 3.3% CAGR by 2034 | Fact.MR Report [Yahoo! Finance]Yahoo! Finance
- Reasons to Retain STE Stock in Your Portfolio Now [Yahoo! Finance]Yahoo! Finance
- Globus Medical, Inc. (NYSE: GMED) had its price target raised by analysts at Roth Mkm from $100.00 to $115.00. They now have a "buy" rating on the stock.MarketBeat
- Globus Medical, Inc. (NYSE: GMED) had its price target raised by analysts at BTIG Research from $87.00 to $91.00. They now have a "buy" rating on the stock.MarketBeat
GMED
Earnings
- 11/5/24 - Beat
GMED
Sec Filings
- 12/4/24 - Form 4
- 12/2/24 - Form 144
- 11/25/24 - Form 4
- GMED's page on the SEC website